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Abstract
We recently discovered, using Fos immunostaining, that the tuberal and mammillary hypothalamus contain a massive
population of neurons specifically activated during paradoxical sleep (PS) hypersomnia. We further showed that some of the
activated neurons of the tuberal hypothalamus express the melanin concentrating hormone (MCH) neuropeptide and that
icv injection of MCH induces a strong increase in PS quantity. However, the chemical nature of the majority of the neurons
activated during PS had not been characterized. To determine whether these neurons are GABAergic, we combined in situ
hybridization of GAD67 mRNA with immunohistochemical detection of Fos in control, PS deprived and PS hypersomniac
rats. We found that 74% of the very large population of Fos-labeled neurons located in the tuberal hypothalamus after PS
hypersomnia were GAD-positive. We further demonstrated combining MCH immunohistochemistry and GAD67 in situ
hybridization that 85% of the MCH neurons were also GAD-positive. Finally, based on the number of Fos-ir/GAD
+, Fos-ir/
MCH
+, and GAD
+/MCH
+ double-labeled neurons counted from three sets of double-staining, we uncovered that around
80% of the large number of the Fos-ir/GAD
+ neurons located in the tuberal hypothalamus after PS hypersomnia do not
contain MCH. Based on these and previous results, we propose that the non-MCH Fos/GABAergic neuronal population
could be involved in PS induction and maintenance while the Fos/MCH/GABAergic neurons could be involved in the
homeostatic regulation of PS. Further investigations will be needed to corroborate this original hypothesis.
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Introduction
The brainstem is necessary and sufficient to generate
paradoxical sleep (PS; also called rapid-eye-movement (REM)
sleep) in cats since many aspects of PS persists after removal of
the brain regions rostral to it [1,2,3]. PS also persists after
mesencephalic trans-sections in rats [4]. However, a growing
number of evidence suggests that the tuberal and mammillary
hypothalamus might also contribute to PS control. Bilateral
injections of muscimol in the cat mammillary and tuberal
hypothalamus induce a robust inhibition of PS [5]. In addition,
neurons specifically active during PS were recorded in the tuberal
hypothalamus of rats [6,7,8,9]. Supporting this hypothesis, we
recently demonstrated using Fos immunohistochemistry as a
marker of neuronal activity that the tuberal and mammillary
hypothalamus contain a very large number of neurons activated
during PS hypersomnia elicited by PS deprivation [10,11]. We
further found that some of these neurons were immunoreactive
(-ir) to melanin concentrating hormone (MCH) and none of them
were immunoreactive to hypocretin [11]. In line with these
findings, it has been shown with unit recordings that the MCH
and hypocretin/orexin neurons are specifically active during PS
and waking, respectively [9,12,13]. However, the biochemical
nature of the large majority of the PS-activated neurons remained
to be determined.
Previous data has shown that the tuberal and mammillary
hypothalamus contain a very large number of GABAergic neurons
[14]. It has been suggested that the MCH neurons might co-
contain GABA [15]. Therefore, to determine whether at least part
of the neurons of the tuberal and mammillary hypothalamus
activated during PS hypersomnia including those expressing MCH
are GABAergic, we combined immunohistochemical detection of
Fos with non-radioactive in situ hybridization (ISH) of the isoform
67 of GAD mRNA. The double-staining was performed in control
rats (PSC), rats deprived of PS (PSD) with the inverted flowerpot
method, and rats allowed to recover after such deprivation (PSR).
We also combined immunohistochemistry of MCH with non-
radioactive ISH of GAD67 mRNA in control rats or with Fos
immunohistochemistry in PSR rats.
Results
Polysomnographic analysis
During the last 150 min before perfusion PSD rats displayed
negligible PS amounts (0.07% (0.00 ; 0.15)) (median (Q1 ; Q3))
whereas PSC and PSR rats spent respectively 9.40% (8.17 ; 11.73)
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spent significantly more time in PS compared to PSC and PSD rats
(p,0.05). During this period, PSD animals spent significantly more
time in wakefulness (64.25% (62.10 ; 68.16)) than animals from the
two other groups (PSC: 40.45% (33.36 ; 48.10), p,0.05; PSR:
25.13% (17.85 ; 26.15), p,0.05). In contrast to PS and waking, the
quantity of slow-wave-sleep did not differ significantly between PSD
(35.72% (31.71; 38.00)) and PSR (37.10% (28.77 ; 39.10)).
Fos distribution in the tuberal and mammillary
hypothalamus
Overall, 3116 (2402 ; 4420), 1311 (1192; 1483) and 399 (193; 605)
Fos-labeled neurons were counted in the tuberal and mammillary
hypothalamus in PSR, PSD and PSC animals, respectively.
The tuberal hypothalamus (all structures located between 22.3
to 23.4 from Bregma, from which we excluded the ventromedial
hypothalamic (VMH) and the arcuate (Arc) nuclei contained 60,
66 and 69% of the Fos-ir neurons in PSR, PSD and PSC
conditions, respectively.
Among the 21 structures of the tuberal (including the Arc and
VMH) and mammillary hypothalamus (all structures located
between 23.4 to 25.0 from Bregma), none contained more Fos-
labeled cells in PSD animals than in PSR ones. Eighteen structures
contained significantly more Fos-labeled cells in PSR than PSC
condition. Thirteen structures contained more Fos-labeled cells in
PSD than PSC animals.
The number of Fos-labeled cells was significantly larger in PSR
than in PSC and PSD conditions in 11 structures, namely the
rostral zona incerta (rZI), the dorsomedial hypothalamic nucleus
(DM), the medial tuberal nucleus (MTu), the tuberal part of the
lateral hypothalamic area (tLH), the perifornical nucleus (PeF), the
tuber cinereum (TC), the posterior hypothalamic area (PH), the
VMH, the Arc, the ventral part of the premammillary nucleus
(PMV) and the supramammillary nucleus (SuM). All of them,
except the VMH, the Arc and the PMV, contained more Fos-ir
cells in PSD condition compared with PSC.
Seven structures contained significantly more Fos-labeled cells
in PSR than in PSC but not PSD conditions namely the ventral
part of the zona incerta (ZIV), the subincertal nucleus (SubI), the
dorsal hypothalamic area (DA), the periventricular nucleus (Pe),
the mammillary part of the lateral hypothalamic area (mLH), the
mammillary nucleus (M) and the submammillothalamic nucleus
(SMT). These structures, except the SubI and the SMT, contained
significantly more Fos-labeled cells in PSD than in PSC condition.
In the three remaining structures, the dorsal zona incerta (ZID),
the dorsal part of the premammillary nucleus (PMD) and the
ventral tuberomammillary nucleus (VTM), the number of Fos-ir
cells did not differ across experimental conditions.
These results are detailed in table 1 and illustrated in figures 1–4.
Distribution of the Fos-ir/GAD
+ double-labeled neurons
in the tuberal and mammillary hypothalamus
Overall, 1591 (1298; 2274), 676 (571; 765) and 178 (104; 260)
Fos-ir/GAD
+ neurons were counted in the tuberal and mammil-
lary hypothalamus in PSR, PSD and PSC animals, respectively
(Table 2). They accounted for 44 to 52% of the total number of
Fos-labeled neurons.
The Fos-ir/GAD
+ neurons constituted 74%, 66% and 62% of
the total number of Fos-ir in the tuberal hypothalamus (excluding
the VMH and Arc) in PSR, PSD and PSC animals, respectively
(Table 3, Figs. 1, 2). In contrast, the Fos-ir/GAD
+ represented only
16, 24 and 7% of the total number of Fos-ir in the mammillary
hypothalamus in PSR, PSD and PSC rats, respectively (Table 3,
Figs.2,3,4).Theseresultsindicatethat Fos-irneurons located inthe
tuberal hypothalamus are mainly GABAergic while those located in
the mammillary hypothalamus are not.
Eight out of the 12 structures composing the tuberal
hypothalamus contained a larger number of Fos-ir/GAD
+ in
PSR than in PSD and PSC animals, namely the rZI, the DA, the
DM, the Pe, the TC, the MTu, the tLH and the PeF. All these
structures, except the MTu and the TC, contained a larger
number of Fos-ir/GAD
+ in PSD than in PSC animals (Table 2,
Figs. 1, 2). The rZi, the PeF and the tLH contained three times
more and the DA, the DM and the Pe twice as many double-
labeled cells in PSR than in PSD condition (Table 2).
The last 4 structures of the tuberal hypothalamus, namely the
ZIV, the SubI, the VMH and the Arc, contained significantly
more Fos-ir/GAD
+ cells in PSR than PSC animals. The difference
was not significant compared to the PSD condition. In the VMH
and Arc, the number of Fos-ir/GAD
+ neurons was also
significantly larger in PSD than in PSC condition.
Finally, only two of the structures of the mammillary
hypothalamus had a significant number of Fos-ir/GAD
+ neurons,
namely the mLH and the PH. They both contained more double-
labeled cells in PSR and PSD than in PSC animals. The number
of Fos-ir/GAD
+ did not significantly differ between PSR and PSD
animals (Table 2, Figs. 2, 3, 4).
MCH immunohistochemistry and GAD67 mRNA double-
staining
As reported by us and others [16,17], most of the MCH-ir cells
were localized in the tuberal hypothalamus. Most of them were
located in the ZI, the LH, and the PeF (Fig. 5). Some cells were
scattered throughout the DM and the PH. The region containing
MCH cells extended over a rostro-caudal distance of 2 mm
(22.10 mm to 23.90 mm from Bregma) (Fig. 5B,C).
A large proportion of MCH-ircells, 841 (829 ; 876.5)neurons out
of 1005 (997 ; 1020.5); 85% (83.2 ; 86.5) was found to express
GAD67 mRNA (Fig. 5). No segregation of double-labeled cells in a
given area was observed (Fig. 5C). Indeed, after counting and
expressing graphically the number of plotted cells per hemisection,
we found that the largest numbers of MCH-ir cells were distributed
in sections extending from 22.70 to 23.60 mm from Bregma
(Fig. 5B, C) and that the MCH-ir cells co-expressing GAD67 mRNA
closely followed the same pattern of distribution (Fig. 5B).
Numbers of Fos-ir/MCH
+,M C H
+/GAD
+ and Fos-ir/GAD
+
double-labeled neurons
To determine the proportion of MCH and non-MCH Fos-ir/
GAD
+ neurons, counts of neurons were made on two hemi-
sections (22.7 and 23.3 mm from Bregma) double-stained for
Fos/MCH or Fos/GAD in PSR animals and for MCH/GAD in
control animals.
We found a total of 14676420 Fos-ir/GAD
+, 41467 MCH
+/
GAD
+ (47616 MCH
+/GAD2) and 293630 Fos-ir/MCH
+
(214620 single MCH
+) double-labeled neurons in the tuberal
hypothalamus.
These results indicate that no more than 20% (293/1467) of the
Fos-ir/GAD+ neurons of the tuberal hypothalamus contain MCH.
Discussion
We report here for the first time that 74% of the very large
number of Fos-labeled cells located in the tuberal hypothalamus
after PS recovery express GAD67 mRNA. We also demonstrate
that 85% of the MCH neurons express GAD67 mRNA. We
uncovered that approximately 20% of the GABAergic neurons
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percentage of the numerous Fos-labeled neurons localized in the
mammillary hypothalamus expressed GAD67 mRNA. After
discussing methodological issues, we will compare our data with
previous studies and discuss the potential role of such an important
neuronal population in the control of PS.
Technical considerations
Despite the fact that Fos immunohistochemistry was combined
with GAD ISH, the distribution and number of Fos-ir labeled
neurons in the tuberal and mammillary hypothalamus observed
here were similar to those reported in our previous work using the
same Fos antiserum and PS deprivation/recovery method [10].
The distribution of GAD-labeled neurons was also in agreement
with previous studies [14,18]. These observations confirm that our
double-staining method combining Fos immunostaining with
GAD67 ISH is well suited to reveal activated GABAergic neurons.
Fos is an immediate early gene with a fast and transient induction
curve in activated neurons and a low level of expression under basal
condition [19]. The half-life of the Fos protein is of approximately
40 min and less than 5% of protein remains 3 hours after
stimulation [20,21]. It is therefore a good tool to map neurons
activated in response to pharmacological stimuli and physiological
challenges. The main criticism of this method is that Fos expression
is not strictly correlated with neuronal activity [22]. We cannot rule
out that some activated neuronal populations are not seen.
However, the identification of neurons specifically active during
PS using Fos method was confirmed by single-unit recordings in the
three structures examined so far. Indeed, neurons discharging
specifically during PS were recorded in the tuberal hypothalamus
[8,23] some of them being characterized as MCH neurons [9], in
the dorsal paragigantocellular nucleus [24] and in the sublater-
odorsal tegmental nucleus [25]. Furthermore, Fos immunostaining
has been extensively used in recent years to identify the neuronal
network of PS [10,11,17,26,27,28,29,30,31,32,33,34]. Another
recurrent criticism of our approach is that the inverted flowerpot
PS deprivation method disrupts energy balance and induces
hyperphagia [35] and chronic stress [36]. However, a more
recent report indicates that hyperphagia is observed after 5 days
of PS deprivation and not after 72 hours [37]. We are aware that
some neurons might be Fos-labeled after PS deprivation due to
Table 1. Number of activated neurons in Control, Paradoxical sleep deprived rats or rats with hypersomnia in paradoxical sleep.
Total Fos-ir
n PSC PSD PSR
Tuberal Hypothalamus
rZI 2 55.0 (39.5 ; 71.0) 141.0* (111.5 ; 171.8) 433.0*,# (320.0 ; 599.0)
ZID 2 2.0 (0.8 ; 6.2) 19.5 (5.8 ; 34.0) 36.0 (11.5 ; 77.0)
ZIV 2 9.0 (6.3 ; 10.3) 23.5* (14.3 ; 42.5) 48.0* (25.3 ; 71.3)
SubI 2 17.0 (8.3 ; 28.0) 39.0 (35.0 ; 54.0) 70.0* (53.5 ; 105.3)
DA 2 42.5 (19.8 ; 69.5) 166.0* (138.5 ; 187.5) 255.0* (198.5 ; 372.0)
DM 2 33.0 (18.3 ; 48.3) 106.0* (97.3 ; 111.3) 183.0*,# (156.8 ; 294.0)
Pe 3 10.5 (7.8 ; 12.3) 34.0* (26.0 ; 44.3) 61.5* (49.5 ; 81.8)
MTu 2 6.5 (5.8 ; 7.8) 28.0* (27.5 ; 29.8) 127.0*,# (96.5 ; 160.0)
tLH 2 45.5 (17.5 ; 83.8) 165.0* (153.0 ; 173.3) 345*,# (221.5 ; 526.3)
PeF 2 10.5 (7.8 ; 12.8) 75.0* (62.8 ; 78.5) 162.0*,# (157.3 ; 203.0)
TC 3 24.5 (6.8 ; 43.0) 78.0* (63.5 ; 96.0) 192.5*,# (167.8 ; 314.5)
VMH 3 20.0 (11.8 ; 31.8) 51.5 (43.3 ; 59.0) 240.0*,# (173.0 ; 347.5)
Arc 4 25.0 (9.3 ; 56.3) 80.0 (71.0 ; 91.3) 184.5*,# (164.0 ; 249.3)
Mammillary Hypothalamus
mLH 1 35.0 (12.8 ; 60.8) 87.0* (78.0 ; 107.8) 134.5* (103.3 ; 199.5)
PH 1 43.0 (20.3 ; 67.8) 163.0* (131.0 ; 187.3) 554.5*,# (406.5 ; 692.0)
PMV 1 1.0 (0.8 ; 4.0) 9.0 (6.3 ; 12.5) 100.5*,# (74.0 ; 121.3)
PMD 1 2.5 (0.8 ; 5.3) 2.5 (0.0 ; 5.3) 17.0 (11.3 ; 25.3)
M 2 6.0 (4.5 ; 11.5) 63.0* (38.0 ; 84.3) 70.5* (64.5 ; 75.3)
VTM 2 1.5 (1.0 ; 2.3) 7.0 (5.0 ; 9.8) 8.5 (1.5 ; 15.0)
SuM 2 18.5 (12.5 ; 28.3) 106.5* (80.8 ; 134.5) 289.5*,# (215.5 ; 371.5)
SMT 1 0.0 (0.0 ; 0.0) 9.5 (7.8 ; 13.5) 36.0* (19.5 ; 54.3)
Number (median(Q1; Q3)) of Fos-ir neurons counted in the tuberal and mammillary hypothalamus in PSC, PSD and PSR rats on a total of 6 sections at 600mm intervals
after Fos immunohistochemistry combined with GAD67 mRNA in situ hybridization. The values displayed are the median across 4 animals in each group of all Fos-ir
neurons (Total Fos
+) one or several sections (column n) depending on the rostrocaudal extent of the structures. Significance values are: *P,0.05 vs PSC;
#P,0.05
between PSR and PSD. Abbreviations: Arc: arcuate nucleus; DA: dorsal hypothalamic area; DM: dorsomedial hypothalamic nucleus; M: mammillary nucleus (including the
lateral mammillary nucleus (LM), the lateral, medial, and median parts of the medial mammillary nucleus (ML, MM and MMn)); mLH: lateral hypothalamic area,
mammillary part; MTu: medial tuberal nucleus; Pe: periventricular nucleus; PeF: perifornical nucleus; PH: posterior hypothalamic area; PMD: premammillary nucleus,
dorsal part; PMV: premammillary nucleus, ventral part; rZI: zona incerta, rostral part; SMT: submammillothalamic nucleus; SubI: subincertal nucleus; SuM:
supramammillary nucleus; TC: tuber cinereum area; tLH: lateral hypothalamic area, tuberal part; VMH: ventromedial hypothalamic nucleus; VTM: ventral
tuberomammillary nucleus; ZID: zona incerta, dorsal part; ZIV: zona incerta, ventral part.
doi:10.1371/journal.pone.0011766.t001
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recordings using juxtacellular labeling would be needed to
confirm that the Fos-ir/GAD
+ neurons discharge specifically
during PS as done previously with other structures [9,12]. The
Fos-labeling method is nevertheless very interesting since in
contrast to electrophysiological recordings, it provides a full map
of the activated neurons. Although the PS deprivation method
and the Fos immunostaining have their drawbacks, the
combination of the two is still the only available method to
map PS-inhibitory and PS-executive structures.
Figure 1. Illustration of activated GABAergic neurons in the rostral part of the zona incerta and lateral hypothalamic area after
paradoxical sleep hypersomnia. Low power photomicrographs illustrating Fos-ir and GAD67 mRNA labeled neurons in the rostral part of the zona
incerta (A1) and the lateral hypothalamic area (B1) from a PSR rat. Numerous Fos-ir (brown nuclear staining) and GAD
+ neurons (blue diffuse
cytoplasmic staining) are observed in the rZI (A2), and the LHA (B2) and (B3) at high magnification. A large part of these neurons are double-labeled.
B4 is an enlargement of B3 showing Fos-ir/GAD
+ cells (black stars) surrounded by Fos-negative/GAD
+ cells. In agreement with previous descriptions
[14], a large number of GAD67 mRNA labeled neurons (black) are distributed in zona incerta, the anterior and dorsomedial hypothalamic nuclei, the
perifornical nucleus and the arcuate nucleus (A1, B1). A large but with a lesser density, number of GAD67 cells was found in the dorsal and lateral
hypothalamic areas (B1). No labeling was observed in the ventromedial nucleus of the hypothalamus (B1). Abbreviations: 3V: 3
rd ventricle; f: fornix;
aLH: lateral hypothalamic area, anterior part; mt: mammillothalamic tract; opt: optic tract; Rt: reticular nucleus of the thalamus; rZI: zona incerta,
rostral part; SubI: subincertal nucleus; tLH: lateral hypothalamic area, tuberal part; VMH: ventromedial hypothalamic nucleus; ZID: zona incerta, dorsal
part; ZIV: zona incerta, ventral part. Scale bars, 500mm for A1 and B1; 50mm for A2, B2 and B3 and 25mm for B4.
doi:10.1371/journal.pone.0011766.g001
Hypothalamic Regulation of PS
PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11766Functional significance
The most noteworthy result of the present study is the very large
number of Fos/GAD
+ double-labeled neurons counted in the
tuberal hypothalamus in PSR animals. When comparing the
results with data recently published on the brainstem [38], it is
interesting to emphasize that, in PSR animals, the tuberal and
mammillary hypothalamus contained 2.5 times more Fos-ir/
GAD
+ labeled neurons than the entire brainstem. Such a
comparison can be carried out because the same animals were
used in both studies and the brainstem and hypothalamic sections
were histologically processed at the same time. This observation is
surprising because pioneer studies of trans-sections in cats showed
Figure 2. Schematic distribution of Fos-ir (small black dots) and Fos-ir/GAD
+ (large red dots) neurons on 4 coronal sections taken at
600mm intervals in a representative animal for PSC (left hand side), PSD (middle) and PSR (right hand side) conditions after Fos
immunohistochemistry combined with GAD67 in situ hybridization. Sections from 22.00 to 23.80 from Bregma (ß). Abbreviations: AH:
anterior hypothalamic area; aLH: lateral hypothalamic area, anterior part; Arc: arcuate nucleus; cp: cerebral peduncle; DA: dorsal hypothalamic area;
DM: dorsomedial hypothalamic nucleus; f: fornix; ic: internal capsule; ml: medial lemniscus; mLH: lateral hypothalamic area, mammillary part; mt:
mammillothalamic tract; opt: optic tract; MTu: medial tuberal nucleus; Pe: periventricular nucleus; PeF: perifornical nucleus; PH: posterior
hypothalamic area; PMV: premammillary nucleus, ventral part; PVN: paraventricular hypothalamic nucleus; rZI: zona incerta, rostral part; SubI:
subincertal nucleus; STh: subthalamic nucleus; TC: tuber cinereum area; Te: terete hypothalamic nucleus; tLH: lateral hypothalamic area, tuberal part;
VM: ventromedial thalamic nucleus; VMH: ventromedial hypothalamic nucleus; ZID: zona incerta, dorsal part; ZIV: zona incerta, ventral part.
doi:10.1371/journal.pone.0011766.g002
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+ Single- and double-labeled neurons in the perifornical nucleus, in the posterior hypothalamic area and
the supramammillary nucleus after paradoxical sleep hypersomnia. Low power photomicrographs show Fos and GAD67 double-labeled
frontal sections at the level of the caudal part of the perifornical nucleus (A1), the mammillary hypothalamus (B1) and the mammillary nuclei (C1) in a
PSR animal. Enlargement in A2 shows several Fos-ir/GAD
+ neurons characterized by a brown nuclear and a blue diffuse cytoplasmic staining (black
stars) and GABAergic singly-labeled cells (open arrows) in the perifornical nucleus. In contrast, B2 show that at mammillary hypothalamic level a
majority of Fos-ir are singly-labeled in the posterior hypothalamic area. Finally, C2 shows that neurons of the supramammillary nucleus are all singly-
labeled by Fos. In agreement with previous descriptions [14], only a few GAD67 labeled cells are located in the suprammammillary and the
mammillary nuclei (C1) compared to the other tuberal and mammillary hypothalamic nuclei (A1, A2). Importantly, although the posterior
hypothalamic area contains a large number of GAD67 labeled cells, most of them are not Fos-ir in contrast to those located more rostrally in the
perifornical and lateral hypothalamic areas (A1). Abbreviations: 3V: 3
rd ventricle; f: fornix; ic: internal capsule; mLH: lateral hypothalamic area,
mammillary part; MRe: mammillary recess of the 3
rd ventricle; mt: mammillothalamic tract; PeF: perifornical nucleus; PH: posterior hypothalamic area;
pm: mammillary peduncle; SuM: supramammillary nucleus. Scale bars: 500mm for A1, B1 and C1; 25mm for A2 and 50mm for B2 and C2.
doi:10.1371/journal.pone.0011766.g003
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the brainstem indicating that the brainstem is necessary and
sufficient to generate PS [1,2,3]. Nevertheless, it is in agreement
with the fact that the inactivation of the tuberal and mammillary
hypothalamus by muscimol applications almost completely
abolishes PS [5]. These and the present results suggest that
although the basic machinery for generating PS is contained
within the brainstem, GABAergic neurons of the tuberal
hypothalamus play an important role in the regulation of PS.
We previously found that a significant number of the Fos-labeled
neurons located in the tuberal hypothalamus in PSR animals are
immunoreactive to MCH [11,17]. We report here that 74% of the
Fos-labeled neurons located in the same region in PSR animals
express GAD67 mRNA. Although it was suspected, we further
provide the first direct demonstration that most of the MCH
neurons (85%) express GAD67 mRNA. Altogether, our results
reveal the existence of two sub-populations of GABAergic neurons
active during PS: a large population of non-MCH/GABAergic
neurons (<4/5 of the Fos-ir/GAD
+), and a population of neurons
co-containing MCH and GABA (<1/5 of the Fos-ir/GAD
+), both
populations being intermingled in the tuberal hypothalamus.
It has recently been shown using juxtacellular recordings that
the MCH neurons fire only during PS and start firing at the onset
of PS [9]. We thus propose that MCH/GABAergic neurons are
involved in the maintenance of PS and not in its induction [39].
Interestingly, ICV administration of MCH [11] and local injection
of MCH within the dorsal raphe [40] induce a strong increase in
PS quantity while subcutaneous injection of MCH receptors
antagonists induces a decrease in PS quantity [41]. Altogether,
these data suggest that the MCH/GABAergic neurons play a
crucial role in the homeostatic regulation of PS (for review see
[39]).
Regarding the large population of non-MCH/GABAergic
neurons found in the present study, it is likely that they also fire
specifically during PS. In support of this hypothesis, a large
number of neurons with specific activation during PS and
displaying a much higher firing rate during PS than the MCH
neurons were recorded in the tuberal hypothalamus in head-
restrained rats [8,23]. Furthermore, in contrast to the MCH
neurons, many of these PS-active neurons increased their firing
rate prior to the onset of PS suggesting that they are able to
maintain but also to induce PS. Although it is speculative and
many more studies need to be carried out, we propose that the
non-MCH/GABAergic neurons belong to this class of neurons
and may be responsible for the inhibition of the local hypocretin
and histaminergic neurons at the onset and during PS. In return,
the GABAergic neurons that were found in the present study to be
Fos-positive after PS deprivation may inhibit the local PS-active
GABAergic neurons during waking and slow-wave-sleep and thus
prevent the onset of PS during deprivation.
In summary, we propose that non-MCH/GABAergic neurons
of the tuberal hypothalamus active during PS would play a key
role in PS induction and maintenance by means of their inhibition
of the co-localized wake-active hypocretin and histaminergic
neurons. The MCH/GABAergic neurons may play a role in PS
homeostasis via their projections to wake-active monoaminergic
neurons, slow-wave-sleep-active neurons of the ventrolateral
preoptic area and the PS-inhibitory GABAergic neurons of the
brainstem vlPAG/dDPMe.
Materials and Methods
Sprague–Dawley male rats were housed under a constant light/
dark cycle (lights on from 7:00 AM to 7:00 PM). The room
Figure 4. Schematic distribution of Fos-ir (small black dots) and Fos-ir/GAD
+ (large red dots) neurons on 2 coronal sections taken at
600mm intervals in a representative animal for PSC (left hand side), PSD (middle) and PSR (right hand side) conditions after Fos
immunohistochemistry combined with GAD67 mRNA in situ hybridization. Sections from 24.40 to 25.00 from Bregma (ß). Abbreviations:
Arc: arcuate nucleus; cp: cerebral peduncle; f: fornix; LM: lateral mammillary nucleus; ML: medial mammillary nucleus, lateral part; MM: medial
mammillary nucleus, medial part; MMn: medial mammillary nucleus, median part; mp: mammillary peduncle; pm: principal mammillary tract; PMD:
premammillary nucleus, dorsal part; SMT: submammillothalamic nucleus; SN: substantia nigra; STh: subthalamic nucleus; SuM: supramammillary
nucleus; VTM: ventral tuberomammillary nucleus.
doi:10.1371/journal.pone.0011766.g004
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and water were available ad libitum throughout the experiment.
Study of activated neurons after PS deprivation or
hypersomnia
Eighteen rats (200–230g, Charles River, France) were implant-
ed for electroencephalogram (EEG) and electromyogram (EMG)
recording and were subjected to a PS deprivation/hypersomnia
protocol. Animals were then perfused with a fixative solution and
brains were removed and sliced in coronal sections. Experimental
protocols performed on animals were approved by the institutional
animal care and use committee of the University of Lyon 1
(protocol BH 2006–09; BH 2006–10).
EEG and EMG recording. Animals were implanted with
EEG and EMG electrodes under chloral hydrate anesthesia
(400 mg/kg, i.p.). Four stainless steel screws were fixed in the
occipital, parietal, and frontal parts of the skull and two wire
electrodes were inserted into the neck muscles. All leads were
connected to a miniature plug that was cemented to the skull.
After surgery, rats were placed on a bed of woodchips in a 30 cm
diameter, 40 cm height Plexiglas jar for the duration of the
experiment. Animals recovered from surgery for 5 days before
being transferred to the recording chamber where they became
accustomed to the recording conditions (environment and cable)
for the next 4 days.
For polygraphic recordings, rats were connected to a cable
attached to a rotating connector to allow free movements of the
animal within the jar. EEG and EMG bipolar signals were
amplified, digitized at 250 Hz and collected with CED using
Spike-2 interface software (Cambridge Electronic Design, Cam-
bridge, UK). Hypnograms were scored off-line manually by using
cortical EEG and nuchal EMG. The episodes of each vigilance
state were scored by using a 10-sec sliding time window according
to the following criteria: wake was characterized by desynchro-
nized low-voltage and high-frequency activity EEG and by a
sustained EMG neck muscle tone; slow-wave-sleep was charac-
terized by high-voltage slow waves (1.5–4 Hz) and spindles (10–
14 Hz) combined to a low muscle tone; PS episodes were
identified by a decrease in the EEG amplitude and a prominent
theta rhythm (5–9 Hz) associated with a muscle atonia on the
EMG. For 4 PSC, 5 PSD and 7 PSR rats, the last 150 min of
EEG/EMG recordings before sacrifice were analyzed in order to
determine time spent in each vigilance state and the number and
duration of wake, slow-wave-sleep and PS bouts.
Paradoxical sleep deprivation and recovery. PS depriva-
tion was performed using the inverted flowerpot technique that has
been previouslyshown to induce a fairly selective deprivation of PSin
Table 2. Number of GABAergic activated neurons in Control, Paradoxical sleep deprived rats or rats with hypersomnia in
paradoxical sleep.
Fos-ir/GAD+
n PSC PSD PSR
Tuberal Hypothalamus
rZI 2 44.5 (30.3 ; 58.0) 128.0* (105.5 ; 149.3) 385.0*,# (302.0 ; 524.3)
ZID 2 2.0 (0.8 ; 4.0) 13.0 (5.0 ; 21.8) 28.0 (10.3 ; 61.5)
ZIV 2 8.0 (5.5 ; 9.5) 21.5 (12.8 ; 37.8) 46.5* (25.3 ; 66.8)
SubI 2 11.5 (6.0 ; 20.8) 34.0 (25.8 ; 47.3) 62.5* (50.0 ; 93.8)
DA 2 18.5 (7.8 ; 30.8) 54.5* (46.3 ; 59.5) 106.5*,# (91.5 ; 162.3)
DM 2 25.5 (12.8 ; 36.8) 73.0* (68.8 ; 75.0) 116.5*,# (103.5 ; 196.0)
Pe 3 4.5 (3.5 ; 5.5) 21.0* (18.0 ; 23.8) 32.0*,# (30.0 ; 42.8)
MTu 2 2.5 (1.8 ; 3.3) 16.0 (9.5 ; 20.3) 75.0*,# (66.3 ; 90.0)
tLH 2 24.5 (11.0 ; 45.5) 99.0* (80.3 ; 124.8) 281.0*,# (192.3 ; 395.5)
PeF 2 9.5 (6.8 ; 11.5) 43.5* (33.0 ; 50.5) 135.0*,# (121.5 ; 175.0)
TC 3 7.5 (4.8 ; 14.5) 38.5 (20.5 ; 55.8) 117.5*,# (106.5 ; 186.5)
VMH 3 0.0 (0.0 ; 0.3) 1.5* (1.0 ; 3.5) 9.0* (4.8 ; 17.8)
Arc 4 8.5 (2.3 ; 17.3) 40.5* (31.5 ; 53.3) 108.5* (75.8 ; 141.8)
Mammillary Hypothalamus
mLH 1 2.0 (1.0 ; 4.5) 40.0* (20.0 ; 70.8) 47.0* (37.5 ; 80.8)
PH 1 4.5 (2.8 ; 10.0) 37.5* (25.8 ; 49.8) 93.0* (59.0 ; 147.3)
PMV 1 0.0 (0.0 ; 1.3) 2.0 (0.8 ; 3.0) 4.5 (1.5 ; 9.5)
PMD 1 0.0 (0.0 ; 0.3) 0.5 (0.0 ; 1.5) 0.5 (0.0 ; 2.0)
M 2 0.0 (0.0 ; 0.0) 1.0 (1.0 ; 1.3) 1.0 (0.8 ; 1.8)
VTM 2 0.5 (0.0 ; 1.0) 3.5 (1.8 ; 5.3) 2.5 (0.8 ; 5.8)
SuM 2 0.5 (0.0 ; 1.3) 2.5 (1.8 ; 3.3) 2.5 (1.8 ; 4.3)
SMT 1 0.0 (0.0 ; 0.0) 0.0 (0.0 ; 0.0) 0.0 (0.0 ; 0.3)
Number (median (Q1; Q3)) of Fos-ir/GAD
+ neurons counted in the tuberal and mammillary hypothalamus in PSC, PSD and PSR rats on a total of 6 sections at 600mm
intervals after Fos immunohistochemistry combined with GAD67 mRNA in situ hybridization. The values displayed are the median across 4 animals in each group of all
Fos-ir/GAD
+ double-labeled neurons counted on one or several sections (column n) depending on the rostrocaudal extent of the structures. Significance values are:
*P,0.05 vs PSC;
#P,0.05 between PSR and PSD. Abbreviations are detailed in table 1.
doi:10.1371/journal.pone.0011766.t002
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significant change in adrenal gland weights [43], a measure of stress
level in animals. Rats were divided into 3 groups: control (PSC;
n=5), deprived of PS (PSD; n=5), and PS recovery (PSR; n=8).
The PSC animals remained on a bed of woodchips in the recording
room throughout the experiment. After 48 hours of baseline
recording, PSD and PSR rats were placed (9:00 AM) on a platform
surrounded by 1–2 cm of warm water (,33uC) for 72 h. The
platform was just large enough (6.5 cm in diameter) to hold the
animal.In this setting the animal couldengage in slow-wave-sleep but
not PS because of the loss of muscle tone that occurs during PS. The
platform was well above the water (9 cm height) to limit tail contacts
with water. Each morning (between 9:00 and 10:00 A.M.), in order to
clean their jar, rats were removed from their platform and placed in
another Plexiglas jar where they could groom and stretch. On the last
day, PSR animals were removed from the platform (10:00 A.M.) and
were returned to a dry bed of woodchips in their recording jars to
allow PS recovery (generally occurring after ,30 min of exploration
and grooming). PS rebound can last for several hours after 72 h of PS
deprivation. The total amount of PS during the first 6 hours of
rebound is approximately 30% whereas it accounts for up to 40% in
the first 3 hours (personal observation). Furthermore, synthesis of the
Fos protein is maximal 1–2 hours post-stimulation [44]. Based on
these data, we chose to let rats recover for exactly 150 min after the
f i r s te p i s o d eo fP S .D u r i n gt h a tt i m e ,P S Dr a t sw e r ek e p ts l e e p
deprived on the platform.
Finally, PSC animals were anesthetized for perfusion (at ,1:00
P.M.) followed by PSD rats, then PSR rats.
Perfusion, fixation and section preparation. Under
profound barbiturate anesthesia (pentobarbital, Ceva sante ´
animale, 150 mg/kg, i.p.), rats were transcardially perfused with
Ringer’s lactate solution containing 0.1% heparin followed by
500 ml of a fixative solution composed of 4% paraformaldehyde in
0.1 M phosphate buffer (PB, pH 7.4). Brains were stored
overnight at 4uC in the fixative solution then in 30% sucrose in
0.1 M PB for 3 days. After that, they were rapidly frozen with
CO2 gas and 30 mm-thick coronal sections were cut on a cryostat.
The free-floating sections were collected and stored at 220uCi n
an RNase-free cryoprotective solution (0.05% DEPC, 20%
glycerol, 30% ethylene glycol in 50 mM PB, pH 7.4).
Fos immunohistochemistry combined with GAD67 mRNA
in situ hybridization
The optimal labeling of the tuberal hypothalamus’ GABAergic
neurons by immunohistochemistry is very difficult and requires the
use of colchicine to block axonal transport [18]. This technique is
not compatible with sleep deprivation experiments. Therefore,
GAD was detected by GAD67 in situ hybridization.
As described before [38,45], the antisense probe was obtained
after linearization of the recombinant plasmid containing the
GAD67 cDNA [46] with EcoRV and in vitro transcription using
SP6 RNA polymerase and a non-radioactive digoxigenin (DIG)
RNA labeling kit (Roche Diagnostic, Mannheim, Germany).
Brain sections were successively incubated in a rabbit
antiserum to Fos (1:4000; Ab-5; Oncogene, CA, USA) in
10 mM PB containing 0.9% NaCl and 0.3% Triton-100X
(PBST) for 18h followed by a biotinylated goat anti-rabbit IgG
solution (1:1000; Vector Laboratories, Burlingame, CA, USA)
and then an ABC-HRP solution (1:1000; Elite kit, Vector
Laboratories) both for 90 min. Finally, the sections were
immersed in a 0.05 M Tris-HCl buffer (pH 7.6) containing
0.025% 3.39-diaminobenzidine-4 HCl (DAB, Sigma-Aldrich, St.
Louis, MO, USA) and 0.003% H2O2. Three washes of 10 min in
PBST were performed between each step. The sections were then
rinsed two times in PBST containing 10 mM dithio-threitol
(DTT, Sigma-Aldrich) for 10 min and then in standard saline
citrate solution (SSC 2X) for 10 min. All buffers except for PBST
with DTT contained 0.2% of RNase inhibitor (solution Protect
RNA RNase inhibitor, Sigma-Aldrich).
After these rinses, the sections were placed for 18 h at 65uCi na
hybridization buffer made of NaCl (150 mM), Tris-HCl (8 mM),
Tris-Base (1 mM), NaH2PO4 (6 mM), Na2HPO (5 mM), EDTA
(5 mM), formamide (50%), dextran sulphate (10%), yeast tRNA
(Sigma type III, 1 mg/ml, Sigma-Aldrich), ficoll (0.02%), and
polyvinylpyrrolidone (0.02%) containing 0.5 mg/ml of the DIG-
labeled probe. After hybridization, the sections were washed in a
1X SSC, 50% formamide, 0.1% Tween-20 solution at 55uC twice
for 20 min and treated with 10 mg/ml RNase A (USB, Cleveland,
OH, USA) in Tris 10 mM (pH 8.0) containing 1 mM EDTA and
500 mM NaCl for 15 min at 37uC. They were then rinsed
3610 min with PBST. For immunohistological detection of DIG,
the sections were incubated overnight with anti-DIG conjugated to
alkaline phosphatase (Roche Diagnostic) diluted 1:2000 in PBST
containing 0.2% blocking agent (Roche Diagnostic). After
Table 3. Percent GABAergic activated neurons in Control,
Paradoxical sleep deprived rats or rats with hypersomnia in
paradoxical sleep.
%Fos-GAD+/TotalFos-ir
n PSC PSD PSR
Tuberal
Hypothalamus
rZI 2 78.0 (76.1 ; 81.1) 87.5 (87.2 ; 90.0) 92.6 (89.8 ; 94.5)
ZID 2 70.6 (30.9 ; 100.0) 67.9 (50.5 ; 86.4) 81.2 (67.5 ; 91.8)
ZIV 2 95.0 (89.4 ; 100.0) 88.6 (83.6 ; 91.3) 97.7 (94.0 ; 100.0)
SubI 2 77.2 (67.7 ; 89.9) 77.9 (71.9 ; 82.6) 92.6 (91.0 ; 93.6)
DA 2 43.2 (39.4 ; 48.0) 30.5 (27.5 ; 34.9) 45.7 (41.3 ; 50.9)
DM 2 73.0 (64.7 ; 75.8) 70.7 (69.0 ; 71.0) 70.2 (66.1 ; 71.3)
Pe 3 47.2 (42.9 ; 52.1) 66.3 (51.5 ; 79.5) 61.9 (57.2 ; 64.0)
MTu 2 29.3 (26.4 ; 39.2) 51.4 (34.1 ; 62.9) 64.3 (59.8 ; 68.4)
tLH 2 57.7 (50.5 ;61.7) 68.9 (61.2 ; 81.6) 75.8 (73.2 ; 81.6)
PeF 2 89.4 (66.7 ; 90.2) 57.9 (52.5 ; 64.2) 80.2 (79.2 ; 82.7)
TC 3 48.3 (30.5 ; 66.2) 44.4 (30.8 ; 55.0) 61.1 (59.6 ; 64.0)
VMH 3 0.0 (0.0 ; 0.5) 3.9 (2.1 ; 7.4) 4.9 (2.5 ; 7.0)
Arc 4 30.4 (18.8 ; 45.7) 51.7 (40.5 ; 63.4) 55.4 (40.0 ; 62.9)
Mammillary
Hypothalamus
mLH 1 11.5 (6.0 ; 16.4) 44.4 (25.6 ; 50.8) 38.9 (24.9 ; 50.8)
PH 1 20.3 (11.2 ; 27.4) 24.7 (22.2 ; 26.5) 18.1 (11.0 ; 26.0)
PMV 1 0.0 (0.0 ; 9.6) 17.5 (3.8 ; 31.9) 8.4 (5.0 ; 12.2)
PMD 1 0.0 (0.0 ; 6.3) 10.0 (0.0 ; 27.5) 2.5 (0.0 ; 6.8)
M 2 0.0 (0.0 ; 0.0) 2.8 (1.2 ; 4.4) 1.6 (1.0 ; 2.6)
VTM 2 50.0 (0.0 ; 100.0) 53.3 (32.1 ; 75.0) 38.3 (20.0 ; 55.8)
SuM 2 2.4 (0.0 ; 5.6) 2.2 (1.4 ; 3.2) 0.9 (0.7 ; 1.3)
SMT 1 0.0 (0.0 ; 0.0) 0.0 (0.0 ; 0.0) 0.0 (0.0 ; 0.3)
Percent (median (Q1; Q3)) of Fos-ir/GAD
+ neurons compare to the total number
of Fos-ir cells counted on a total of 6 sections at 600mm intervals after Fos
immunohistochemistry combined with GAD67 mRNA in situ hybridization.
Significance values are: *P,0.05 vs PSC;
#P,0.05 between PSR and PSD.
Abbreviations are detailed in table 1.
doi:10.1371/journal.pone.0011766.t003
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and then in a buffer containing 100 mM Tris (pH 9.5), 100 mM
NaCl and 50 mM MgCl2. The sections were developed at 37uC
for ,4 h in the same buffer with nitroblue tetrazolium (NBT) and
5-bromo-4-chloro-3-indolyl-phosphate (BCIP) diluted 1:50 from
the stock solution (Roche Diagnostic). Incubations were performed
at room temperature unless otherwise noted. Finally, the sections
were mounted on glass slides, dried and coverslipped with
Vectamount (Vector Laboratories). Controls in the absence of
primary antibodies (anti-Fos and anti-DIG) and with the sense
probe (GAD67 cDNA linearised with HindIII restriction enzyme
and transcribed using T7 RNA polymerase) were run to ensure the
Figure 5. Colocalization of MCH neuropeptides and GAD67 mRNA in neurons of the tuberal hypothalamus. (A) Photomicrograph
showing one MCH-ir cell (black star, brown cytoplasmic staining only) and one MCH-ir cell co-expressing GAD67 mRNA (black arrows, brown and blue
diffuse cytoplasmic stainings superimposed) in the lateral hypothalamic area. (B) Graphics illustrating the distribution of MCH-ir cells along the
rostrocaudal axis (from the first to the 7
th section). The upper graph reports the average number of MCH-ir cells (black dots) (median 6 Q1;Q3) and of
MCH-ir/GAD
+ neurons (red dots) counted on hemisections from three rats. The bottom graph illustrates the percent of MCH-ir/GAD
+ cells over the
total number of MCH-ir neurons on each hemisection. (C) Schematic distribution of MCH-ir (black dots) and MCH-ir/GAD
+ (red dots) neurons in on
representative rat brain. The approximate planes of sections relative to Bregma (b), according to the atlas of Paxinos and Watson [51], are 22.10 (1),
22.40 (2), 22.70 (3), 23.00 (4), 3.30 (5), 3.60 (6) and 23.90 (7). Scale bar: 30 mm. Abbreviations: AH: anterior hypothalamic area; Arc: arcuate nucleus;
DA: dorsal hypothalamic area; DM: dorsomedial hypothalamic nucleus; f: fornix; ic: internal capsule; LH: lateral hypothalamic area; ml: medial
lemniscus; mt: mammillothalamic tract; PH: posterior hypothalamic area; PMV: premammillary nucleus, ventral part; PVN: paraventricular
hypothalamic nucleus; opt: optic tract; Rt: reticular thalamic nucleus; SPF: subparafascicular thalamic nucleus; STh: subthalamic nucleus; SubI:
subincertal nucleus; VM: ventromedial thalamic nucleus; VMH: ventromedial hypothalamic nucleus; ZI: zona incerta.
doi:10.1371/journal.pone.0011766.g005
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Fos antiserum was made against a synthetic peptide corresponding
to the N-terminal part (residues 4–17) of human Fos protein. This
part of the protein displays 100% homology between humans and
rats [47,48] and no homology with Fos-related antigens such as
Fos B, Jun B, Fra-1 and Fra-2 (Blast 2 sequences, NCBI). In
agreement with previous studies, very few immunoreactive nuclei
were observed with this Fos antiserum in rat brains following a
control perfusion during daylight [49,50]. Brains from sets of PSC,
PSD, and PSR animals that were run together during the
deprivation/rebound part of the experiment were processed
together for immunohistochemistry and ISH.
Immunohistochemistry of Fos and MCH
We previously showed that MCH neurons are activated only
after PS rebound [11,17]. We therefore performed this double-
labeling on PSR rats (n=4) only. Sections were first processed for
Fos immunohistochemistry as mentioned above except that 0.6%
nickel ammonium sulphate was added to the DAB solution. The
Fos stained sections were incubated the following day in a rabbit
antiserum to MCH (1:100,000; Phoenix Pharmaceutical) in PBST-
Az over 3 days at 4uC. Amplification steps were similar to those
used for Fos but revelation was performed in DAB solution
without nickel [11,17].
Immunohistochemistry of MCH combined with GAD67
mRNA in situ hybridization
Three additional male Sprague-Dawley rats (270–280g, Charles
River, France) underwent the same fixative protocol as described
above. Brains were removed and cut in 25 mm-thick coronal
sections. They were processed for MCH immunohistochemistry
followed by GAD67 ISH using the same method as above. The
only difference was the use of a rabbit antiserum against MCH
(1:5000; Phoenix Pharmaceuticals, Burlingame, CA, USA) instead
of the Fos antibody.
Analysis of immunohistochemical data
Despite the fact that we tried all possible combinations, we were
not able to combine the labeling of Fos, GAD and MCH on the
same sections. To tackle this problem, we used several double
stains on different sections. The distribution of the Fos-ir, Fos-ir/
GAD
+, Fos-ir/MCH
+, MCH-ir and MCH-ir/GAD
+ labeled
neurons was similar between the two hemispheres of the brain.
As such, only hemi-sections were analyzed. Drawings of double-
labeled sections were made with an Axioskop microscope (Zeiss,
Germany) equipped with a motorized X–Y-sensitive stage and a
video camera connected to a computerized image analysis system
(Mercator; ExploraNova, La Rochelle, France). In the Fos/GAD
and the Fos/MCH studies, Fos single- and double-labeled neurons
were plotted on sections taken at 600 mm intervals (6 sections
between AP 22.00 and 25.00 from Bregma) for 4 rats per
condition. For the MCH/GAD study, MCH and MCH/GAD
neurons were plotted on sections taken every 300 mm (7 sections/
rat, between AP 22.10 and 23.90 from Bregma). In all cases, the
number of plotted neurons per structure was counted using
Mercator (ExploraNova). When a structure was present on several
sections the neurons counted on all sections were summed. The
atlas of Paxinos & Watson [51] was used as a reference.
Statistical analysis
Since we compared distribution-free small-size samples, we
performed non-parametric tests and reported median and
quartiles data. Kruskal-Wallis tests were performed on vigilance
state quantities and number of labeled neurons for each structure
across experimental conditions (PSC n=4, PSD n=4 and PSR
n=8). Post-hoc Mann-Whitney tests were used to identify
significant pairwise differences (PSR or PSD vs PSC; PSR vs
PSD). All statistics were performed using StatView v.5.
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